Blue Diamond Ventures Enters Cannabis Extraction Market After Executed Agreement With Michigan Plant Technologies

PLANO, TX--(Marketwired - Aug 18, 2015) - Blue Diamond Ventures (OTC: BLDV) has entered the Cannabis extraction market following its most recent executed agreement with Michigan Plant Technologies (MPT).

Under the agreement terms, Blue Diamond Ventures will purchase a specific model of an Alcohol Cannabis Extractor and lease it to MPT in return for monthly payments. At the end of the lease agreement, MPT will own the equipment.

"Our agreement with Michigan Plant Technologies represents a significant step toward the company achieving its objective of generating revenues and cash flow," said Blue Diamond CEO Cleve Tsai.

The arrangement will provide Blue Diamond with an 80 percent annual return on its investment. Additionally, the agreement allows Blue Diamond, along with our strategic partner, Green Science (GS), access to Research and Develop Cannabis Products derived from extracted oils from the Cannabis Plant. The Research and Development (R&D) facility is located in Three Oaks, Michigan and owned by Michigan Plant Technologies. The R&D facility was founded in 2013 and is compliant with the laws of the State of Michigan and the Michigan Medical Marijuana Program (MMMP).

Green Science, under an agreement with Michigan Plant Technologies (MPT), is the lead project manager for this enterprise and has the ability to utilize the facility to develop products separate and apart from MPT's product line. Blue Diamond's relationship with Green Science grants the company the same rights.

MPT offers fee based services to Midwest Care Givers, a Non-Profit Organization in Michigan, whereby, they provide access to Caregivers (Growers) so they may cultivate Cannabis Plants from seed to harvest; the cannabis plant may be then processed into edible medical cannabis products for their patients who require this form of delivery. Green Science collaborates with the growers and legally processes their plants into finished products at the MPT facility. This relationship grants GS and Blue Diamond access to the raw plant material -- garnered from the trim and, otherwise, discarded plant materials -- needed to perform research and develop products, greatly reducing development costs.

"We are excited to undertake this project with Michigan Plant Technologies," said Green Science's Josh Alper, a trusted and valued partner to Blue Diamond who was instrumental in bringing the negotiations to a successful outcome.

Blue Diamond CEO Cleve Tsai explained Blue Diamond Ventures has already made a 60 percent deposit for the equipment and will pay the remaining balance within the coming days. MPT will be trained on the proper usage of the equipment by the manufacturer, Eden Labs. Blue Diamond will start receiving lease payments from MPT beginning in January 2016.

Shareholders should note that Blue Diamond Ventures has launched its newly revised website www.bldvinc.com

Noting the successful meetings held in Denver by Blue Diamond, Mr. Tsai anticipates closing more transactions in the near future. Blue Diamond Ventures, Inc. will provide updates to the market place when appropriate.

About us:
Blue Diamond Ventures, Inc. targets companies that share a synergy, mission and vision to provide consumers with products that are produced utilizing fewer natural resources and provide a healthy alternative than current traditional products on the market today. As a diversified customer centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities globally in various markets and is driven to surpass all expectations in its performance to achieve the pinnacle of success. 

Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.